Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer

Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer

(2011) G. K. Siddiqui et al.   ANGIOGENESIS

Calpastatin is associated with lymphovascular invasion in breast cancer

(2011) Sarah J. Storr et al.   BREAST

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism

(2011) S Al-Bahlani et al.   ONCOGENE

Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience

(2010) J. Alexandre et al.   ANNALS OF ONCOLOGY

Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy

(2010) Caroline M. Woolston et al.   FREE RADICAL BIOLOGY AND MEDICINE

Calpain-1 expression is associated with relapse-free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy

(2010) Sarah J. Storr et al.   INTERNATIONAL JOURNAL OF CANCER

Activation of calpain-1 in human carotid artery atherosclerotic lesions

(2009) Isabel Gonçalves et al.   BMC Cardiovascular Disorders

Bid and Calpains Cooperate to Trigger Oxaliplatin-Induced Apoptosis of Cervical Carcinoma HeLa Cells

(2009) S. Anguissola et al.   MOLECULAR PHARMACOLOGY

Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin

(2008) Rachel A. Hanna et al.   NATURE

Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains

(2008) Tudor Moldoveanu et al.   NATURE